National Health Investors, Inc.

NYSE NHI

National Health Investors, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending September 30, 2024: 78.69%

National Health Investors, Inc. EBITDA Margin is 78.69% for the Trailing 12 Months (TTM) ending September 30, 2024, a 12.25% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

National Health Investors, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending September 30, 2023 was 70.10%, a 19.76% change year over year.
National Health Investors, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending September 30, 2022 was 58.54%, a -27.31% change year over year.
National Health Investors, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending September 30, 2021 was 80.53%, a -12.19% change year over year.
National Health Investors, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending September 30, 2020 was 91.71%, a -1.60% change year over year.

Key data

Date	EBITDA Margin	EBIT Margin	Depreciation and Amortization	EBIT

NYSE: NHI

National Health Investors, Inc.

CEO	Mr. D. Eric Mendelsohn
IPO Date	Oct. 9, 1991
Location	United States
Headquarters	222 Robert Rose Drive
Employees	26
Sector	Real Estate
Industries Health Care REITs Diversified REITs

Description

Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

Key trends

Past 5 years